Side effects are specific symptoms or reactions that may happen during treatment, such as feeling sick, diarrhoea or constipation
Common Causes and Solutions The table below provides a quick overview of each common cause and the recommended solution
Renal protection with glucagon-like peptide type 1 receptor agonists In CVOTs of arGLP1 renal outcomes were prespecified as key secondary outcomes in 4 studies done with liraglutide, subcutaneous semaglutide, dulaglutide, and efpeglenatide,58,59,63,64 or were collected as safety parameters in other studies.60 Overall, the prevalence of CKD stage 3 in these studies was low (2030%) (Table 1)
Doenhoff, M
It turns out that the idea of tirzepatide producing more significant weight loss than semaglutide in patients with type 2 diabetes isnt new, as demonstrated in a New England Journal of Medicine article reporting clinical data for tirzepatide versus semaglutide once weekly in patients with type 2 diabetes